Scientists Balk At Soaring Journal Prices

In 1984 an annual subscription to Leukemia Research cost a library $160. It’s now $540. In 1985 a year’s worth of Gene was $627.40. This year it’s $1,870. Computers and Structures was $425 in 1983. Today’s rate:, $1,425. Brain Research, a weekly, is now priced at $5,080 per year. “Price gouging,” says Duane Webster, executive director of the Association of Research Libraries (ARL). “Devastating,” says Michael Keller, an associate librarian at the

Written byKen Kalfus
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

In 1984 an annual subscription to Leukemia Research cost a library $160. It’s now $540. In 1985 a year’s worth of Gene was $627.40. This year it’s $1,870. Computers and Structures was $425 in 1983. Today’s rate:, $1,425. Brain Research, a weekly, is now priced at $5,080 per year.

“Price gouging,” says Duane Webster, executive director of the Association of Research Libraries (ARL). “Devastating,” says Michael Keller, an associate librarian at the Sterling Library at Yale University. And Chuck Hamaker, director of the Louisiana State University library, declares that the trend is “horrendous.”

The price of professional science journal is skyrocketing, forcing librarians to cancel subscriptions to old titles and declare moratoriums on accepting new ones. Meanwhile, the researchers who depend on these journals are worried about the free flow of scientific information. They also see the rising unavailability of certain journals hampering their work. As one scientist says, chance ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies